Literature DB >> 13629071

Heinz-body anaemia due to dapsone.

R S SMITH, S ALEXANDER.   

Abstract

Entities:  

Keywords:  AMEMIA, HEMOLYTIC/etiology and pathogenesis; SULFONES/injurious effects

Mesh：

Substances：

Year:  1959        PMID： 13629071      PMCID： PMC1992735          DOI： 10.1136/bmj.1.5122.625

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Dapsone in the treatment of dermatitis herpetiformis.

Authors:  J O ALEXANDER
Journal:  Lancet       Date:  1955-06-11       Impact factor: 79.321

2.  Toxic anemias and Heinz bodies.

Authors:  M H FERTMAN; M B FERTMAN
Journal:  Medicine (Baltimore)       Date:  1955-05       Impact factor: 1.889

3.  Advances in the treatment of skin diseases.

Authors:  H R VICKERS
Journal:  Practitioner       Date:  1954-10

4.  Treatment of dermatitis herpetiformis with diamino-diphenyl-sulphone (D.D.S.).

Authors:  E E KRUIZINGA; H HAMMINGA
Journal:  Dermatologica       Date:  1953

5.  Agranulocytosis Following Dapsone Therapy.

Authors:  W B McKenna; A C Chalmers
Journal:  Br Med J       Date:  1958-02-08
  5 in total
  3 in total

1.  DAPSONE-INDUCED HAEMOLYSIS.

Authors:  C D PENGELLY
Journal:  Br Med J       Date:  1963-09-14

2.  The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.

Authors:  R L Degowin; R B Eppes; R D Powell; P E Carson
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

3.  Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.

Authors:  Taysa Ribeiro Schalcher; Rosivaldo S Borges; Michael D Coleman; João Batista Júnior; Claudio G Salgado; Jose Luiz F Vieira; Pedro R T Romão; Fabio R Oliveira; Marta Chagas Monteiro
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.